Michelle Monje
Michelle Monje-Deisseroth is a neuroscientist and neuro-oncologist who serves as a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. Her research focuses on the intersection of neuroscience, immunology, and brain cancer biology, particularly neuron-glial interactions in health and oncological disease. She is widely credited for pioneering the field of Cancer Neuroscience through her work on how neuronal activity influences glioma growth and progression. Monje has developed new treatments for diffuse intrinsic pontine glioma and other diffuse midline gliomas, including leading clinical trials of panobinostat and GD2-targeted CAR-T cell therapy. Her laboratory established the first cultures of DIPG from patient tissue, enabling global research collaboration and therapeutic testing. She has been recognized with honors such as the NIH Director's Pioneer Award and the Presidential Early Career Award for Scientists and Engineers.
Health Timeline
Newest first - 0 eventsNo health events recorded for Michelle Monje yet. This page updates as coverage is verified.
About this record
Each event is compiled from published reporting and rated for severity by an automated classifier, then shown with its date. Only events concerning Michelle Monje's own health are included. Biographical summary adapted from Wikipedia (source linked above).
0 health events - 0 articles tracked